PharmaState Is Official Media Partner For DUPHAT 2020. Click the banner to explore more...spot_imgspot_imgspot_img

Dilip Shanghvi drew a salary of Rs 1/- during the year 2018-19

-

Mr. Dilip Shanghvi, took a 99% cut in his remuneration in 2018-19 when the Sun Pharma earnings grew by 27%.

Among peers, Shanghvi was one of the lowest-paid CEOs. His remuneration in 2017-18 was Rs 3.36 crore (including a salary of Rs 2.79 cr). He drew a salary of ~ Rs 1/- during 2018-19 as per Sun Pharma’s annual report.

The valuation of Dilip Shanghvi shareholding which is 9.6 % in Sun Pharma on 31st July 2019 was Rs. 9830 crore.

PharmaState Blog
This is a platform for people working in the pharmaceuticals industry for Discussions, Jobs, News updates, Professional Profile display space and company business pages. PharmaState DNA is having four pillars: Quality, Transparency, Innovation & Benchmarks.

Share this article

Recent posts

Popular categories

Leave a Reply

Recent comments

Business Alnavedic on History of Indian Pharma Industry
Ahmed Mohamed Elkhodragy on MACO Calculation
Jennifer Osunde on DEFECTS IN UNCOATED TABLETS
Vinod on DEVIATION
Sunil Kumar M on SITE ACCEPTANCE TEST (SAT)
Khalid on IQ Protocol
Khalid on IQ Protocol
Nagabooshanam on Calibration of Reactor
PharmaState Blog on SOP for Sampling
Swapnil Khodake on TOOLING FOR TABLETING
%d bloggers like this: